IO Biotech, Inc. (IOBT)
NASDAQ: IOBT · Real-Time Price · USD
1.960
-0.190 (-8.84%)
At close: Aug 6, 2025, 4:00 PM
2.010
+0.050 (2.55%)
After-hours: Aug 6, 2025, 7:29 PM EDT
IO Biotech Market Cap
IO Biotech has a market cap or net worth of $129.13 million as of August 6, 2025. Its market cap has increased by 24.05% in one year.
Market Cap
129.13M
Enterprise Value
93.80M
1-Year Change
24.05%
Ranking
Category
Stock Price
$1.96
Market Cap Chart
Since the IPO on November 5, 2021, IO Biotech's market cap has decreased from $369.28M to $129.13M, a decrease of -65.03%. That is a compound annual growth rate of -24.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2025 | 141.64M | 133.70% |
| Dec 31, 2024 | 60.61M | -51.06% |
| Dec 29, 2023 | 123.86M | 86.88% |
| Dec 30, 2022 | 66.28M | -64.06% |
| Dec 31, 2021 | 184.42M | -50.06% |
| Nov 5, 2021 | 369.28M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 690.36B |
| Johnson & Johnson | 411.92B |
| AbbVie | 348.32B |
| AstraZeneca | 229.32B |
| Novartis AG | 226.38B |
| Abbott Laboratories | 226.14B |
| UnitedHealth Group | 218.60B |
| Novo Nordisk | 215.34B |